---
title: "CALDAN THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c6ba18b5-e363-5fc2-ba50-7b65f8a661e3
json: https://whiteintel.dev/api/public/dossier/c6ba18b5-e363-5fc2-ba50-7b65f8a661e3
identifier: oo:GB-COH-SC515558
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CALDAN THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-SC515558`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c6ba18b5-e363-5fc2-ba50-7b65f8a661e3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c6ba18b5-e363-5fc2-ba50-7b65f8a661e3  

## Ownership & control

### Owners / controllers

- **Hna Group Limited** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/39fdd0fe-fde3-4abb-93e5-92894f10de08
- **EPIDAREX CAPITAL II, LP** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/7c669a1a-f152-53b2-9111-16bc3e6b9d02
- **EPIDAREX CAPITAL PARTNERS LIMITED** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a

### UBO chain (walk to the ultimate owner)

A **34-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `SC515558`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2015-09-14
- **Registered office:** 7 St James Terrace, Lochwinnoch Road, Kilmacolm, PA13 4HB
- **SIC:** 72110

### Officers

- CANNING, Mary Eugenie, Dr — director · Irish · appointed 2021-04-22
- GOUGH, Lori Krim, Dr — director · American · appointed 2023-11-15
- MILLIGAN, Graeme — director · British · appointed 2015-09-14
- PAYTON, Mark Anthony, Dr — director · British · appointed 2019-07-31
- ULVEN, Trond — director · Norwegian · appointed 2015-09-14
- ARMSTRONG, Frank, Dr — director · British · appointed 2016-03-08 · resigned 2022-05-31
- DALRYMPLE, Michael Alexander, Doctor — director · British · appointed 2019-06-19 · resigned 2021-03-29
- DUGDALE-BRADLEY, Linda Anne, Dr — director · British · appointed 2021-04-22 · resigned 2023-08-31
- FINAN, Peter Michael, Dr — director · British · appointed 2015-11-09 · resigned 2019-07-31
- ROPER, Elizabeth Ann, Dr — director · Irish · appointed 2015-10-09 · resigned 2021-04-22
- STEINHAGEN, Henning Klaus-Willi Christian, Dr — director · German · appointed 2019-07-31 · resigned 2023-11-15

### Beneficial owners (Persons with Significant Control)

- [Epidarex Capital Ii Lp](https://whiteintel.dev/entity/7c669a1a-f152-53b2-9111-16bc3e6b9d02) — 25–50% shares · corporate PSC · Scotland — since 2016-04-06
- [Scottish Enterprise](https://whiteintel.dev/entity/39fdd0fe-fde3-4abb-93e5-92894f10de08) — 25–50% shares · corporate PSC · N/A — ceased 2016-04-06
- [Epidarex Capital Partners Limited](https://whiteintel.dev/entity/dc909ac3-60ad-52a2-8e31-dcd80d3f0c1a) — 25–50% shares · corporate PSC · Scotland — ceased 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/SC515558
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/SC515558

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CALDAN THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/c6ba18b5-e363-5fc2-ba50-7b65f8a661e3 · Structured JSON: https://whiteintel.dev/api/public/dossier/c6ba18b5-e363-5fc2-ba50-7b65f8a661e3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._